We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zevra Therapeutics (ZVRA – Research Report) today and set a price target ...

Heron Therapeutics Inc (HRTX) stock saw a modest uptick, ending the day at $2.02 which represents a slight increase of $0.07 or 3.59% from the prior close of $1.95. The stock opened at $1.99 and ...

Investment returns and principal value will vary; there may be a gain or loss when shares are sold ... For the second quarter in a row, Sarepta Therapeutics (SRPT) was a top contributor. We have been ...

Multiple suspects are being sought after attempting to break into a Washington Avenue house in the early morning on Friday, ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $36.41 which represents a slight increase of $2.07 or 6.03% from the prior close of $34.34. The stock opened at $35.06 and ...

Beam is another cryptocurrency that has been launched in January, 2019 to enable the users to make confidential transactions ...